BioNTech
BNTX
BNTX
280 hedge funds and large institutions have $4.87B invested in BioNTech in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 90 increasing their positions, 88 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
280
Holders Change
-38
Holders Change %
-11.95%
% of All Funds
4.48%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
32
Increased
90
Reduced
88
Closed
65
Calls
$114M
Puts
$303M
Net Calls
-$189M
Net Calls Change
-$118M
Top Buyers
| 1 |
AGA
1
Altrinsic Global Advisors
Stamford,
Connecticut
|
$68.4M |
| 2 |
2
Morgan Stanley
New York
|
$119M |
| 3 |
3
Primecap Management
Pasadena,
California
|
$570M |
| 4 |
4
Millennium Management
New York
|
$58.7M |
| 5 |
5
Twin Tree Management
Dallas,
Texas
|
$46.8M |
